Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'CJ Corp -Company Report' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| CJ Corp.-Therapeutic Competitors Report | Mar 2011 | £220 | 100% |
| CJ Corp.-Deals & Alliances Report | Mar 2011 | £380 | 99% |
| Global Biosimilars A return to optimism? |
Jan 2012 | £1,295 | 59% |
| Leukemia A Competitive Analysis to New Products, Portfolio Planning, Licensing & Acquisition Through Pipeline Benchmarking |
Apr 2009 | £1,620 | 57% |
| Veterinary Health Markets | May 2010 | £2,150 | 53% |
| A Decision Support Tool for Optimizing The Leukemia Pipeline From Research and Development to Market |
Apr 2011 | £1,620 | 50% |
| Growth Factors ( Blood And Tissue ) | Jan 2011 | £2,845 | 39% |
- Results 1 - 7 of 7
-
-
- 1
-
-
